The chemical class of Gm3696 inhibitors includes a diverse range of compounds, each targeting different aspects of cellular signaling and biochemical pathways, which are hypothesized to influence the activity of the Gm3696 protein indirectly. These inhibitors provide a crucial understanding of the protein's role in various cellular processes and offer a gateway to explore its broader biological functions.
Among these inhibitors, trametinib, cobimetinib, and selumetinib target the MEK enzymes, playing a pivotal role in the MAPK/ERK pathway. This pathway is integral to cell proliferation and survival, suggesting that Gm3696 may be involved in these critical cellular functions. By modulating this pathway, these inhibitors offer insights into the potential regulatory mechanisms of Gm3696.
Ulixertinib, targeting ERK, further underscores the importance of the MAPK/ERK pathway in relation to Gm3696. Its inhibition allows for a more targeted approach to understand how this pathway might influence the function of Gm3696.
Bortezomib and omacetaxine represent a different aspect of the inhibition spectrum, focusing on protein degradation and synthesis, respectively. These compounds provide a window into understanding the protein turnover and synthesis processes that Gm3696 might be associated with, offering a broader view of its cellular role.
Kinase inhibitors like saracatinib, dabrafenib, and ibrutinib target specific kinases such as Src, BRAF, and Bruton's tyrosine kinase. These kinases are crucial in various signaling pathways, indicating that Gm3696 might play a role in signaling processes mediated by these enzymes.
Ruxolitinib and tofacitinib, as JAK inhibitors, bring attention to the cytokine signaling pathways. Their inhibition can shed light on how Gm3696 interacts with these pathways, especially in processes like inflammation and immune response.
Lastly, alpelisib, a PI3K inhibitor, highlights the role of the PI3K/AKT/mTOR pathway, a central pathway in cell growth and metabolism. This suggests a possible link between Gm3696 and metabolic processes or growth signaling.
In summary, the chemical class of Gm3696 inhibitors encompasses a wide range of compounds, each providing unique insights into the protein's function. These inhibitors not only help in understanding the direct and indirect actions of Gm3696 but also pave the way for further research into its role in cellular physiology.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Inhibits MEK, possibly affecting MAPK/ERK pathways that Gm3696 might be involved in. | ||||||
Cobimetinib | 934660-93-2 | sc-507421 | 5 mg | $270.00 | ||
Targets MEK1/2, potentially disrupting signaling pathways connected to Gm3696's function. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
A MEK inhibitor, may affect cell proliferation pathways linked to Gm3696. | ||||||
Ulixertinib | 869886-67-9 | sc-507296 | 10 mg | $176.00 | ||
Inhibits ERK, potentially modulating pathways that interact with Gm3696. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, may indirectly affect protein degradation processes related to Gm3696. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Inhibits protein synthesis, potentially affecting proteins that regulate Gm3696's activity. | ||||||
Saracatinib | 379231-04-6 | sc-364607 sc-364607A | 10 mg 200 mg | $115.00 $1056.00 | 7 | |
Src kinase inhibitor, could modulate signaling pathways relevant to Gm3696's function. | ||||||
Dabrafenib | 1195765-45-7 | sc-364477 sc-364477A sc-364477B sc-364477C sc-364477D | 5 mg 25 mg 50 mg 100 mg 10 g | $141.00 $260.00 $278.00 $411.00 $12485.00 | 6 | |
BRAF inhibitor, may disrupt signaling pathways associated with Gm3696. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Inhibits Bruton's tyrosine kinase, potentially influencing pathways linked to Gm3696. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK inhibitor, might affect signaling cascades relevant to Gm3696's role. | ||||||